Scientific Advisory Board

• Daniel Anderson, Ph.D.
• Alan Colman, Ph.D.
• Hongkui Deng, Ph.D.
• Sheng Ding, Ph.D.
• Rudolf Jaenisch, M.D.
• Jeffrey M. Karp, Ph.D.
• Gordon Keller, Ph.D.
• Robert Langer, Sc.D.
• Douglas A. Melton, Ph.D.
• Roy Ogle, Ph.D.
• Thomas Roberts, Ph.D.
• Lee Rubin, Ph.D.
• Robert Weinberg, Ph.D.
• Leonard Zon, M.D.

Gordon Keller, Ph.D.

Hematopoietic, vascular, and cardiac lineage development from ES cells, lineage specific differentiation in culture, ES cell commitment to endoderm-derived lineages, and growth and differentiation of human ES cells

Senior Scientist, Division of Stem Cell and Developmental Biology, Ontario Cancer Institute

Dr. Gordon Keller earned his PhD in Immunology at the University of Alberta in 1979 and completed a Post Doctoral Fellowship at the Ontario Cancer Institute in Toronto in 1983. Following post doctoral studies, he became a Member of the Basel Institute for Immunology in Switzerland where he worked for five years, then moved to Vienna Austria where he accepted a post of Visiting Scientist at the Research Institute of Molecular Pathology. In 1990, Keller moved to the United States, working initially at the National Jewish Centre for Immunology and Respiratory Medicine in Denver Colorado and from 1999-2006 as a Professor in the Department of Gene and Cell Medicine at the Mt. Sinai School of Medicine in New York. In 2005, he was appointed as the Director of the Black Family Stem Cell Institute within the Mt. Sinai School of Medicine. As of January 2007, Keller returned to Canada to accept the position of Director of the McEwen Centre for Regenerative Medicine at the University Health Network in Toronto. Dr. Keller is best known for his research in lineage specific differentiation of mouse and human embryonic stem cells.